Article Details

VAV Lifesciences inks deal to supply synthetic phospholipids for m-RNA based COVID-19 vaccines

Retrieved on: 2021-04-20 13:39:03

Tags for this article:

Click the tags to see associated articles and topics

VAV Lifesciences inks deal to supply synthetic phospholipids for m-RNA based COVID-19 vaccines. View article details on hiswai:

Excerpt

Since mRNA, on its own, is extremely sensitive to degradation and rapid breakdowns, lipid nanoparticles (LNPs) ensure the protection of the mRNA until ...

Article found on: www.expresspharma.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up